Earnings, Hemp Wars & Biden's Promise 🤞

Curaleaf & MariMed CEOs speak at the Benzinga Cannabis Conference. Battles in New Jersey and Florida around regulation put hemp in the spotlight again. Plus, AFC Gamma hits $100M milestone!

You're receiving this email because you're subscribed to Cannabis Daily from Benzinga. To manage your subscription, click the link at the bottom of this email.

Good morning everyone! Patricio Liddle here. Big things are happening this week as the Benzinga Cannabis Capital Conference kicks off in Chicago! In today’s edition, we’ll talk about industry leaders like Curaleaf and MariMed CEOs sharing insights at the conference, plus the latest on New Jersey and Florida’s hemp battles, and AFC Gamma hitting a huge $100M milestone.

But before we get started, I just wanted to take a moment to sincerely thank you for reading and supporting this content. Your trust in this newsletter means a lot to us. Let’s jump right in!

Curaleaf and MariMed are set to report their Q3 earnings on November 6th. Both companies have been making waves—Curaleaf with its leadership change and MariMed expanding its footprint. Lucky for us, their CEOs, Boris Jordan and Jon Levine, will be speaking today at the Benzinga Cannabis Capital Conference in Chicago.

Speaking of the conference, it's the place to be for all things cannabis. From emerging market trends and investment strategies to crucial discussions about regulation and social equity, the Benzinga Cannabis Conference is where key players connect and share insights on how they are shaping the industry. All this and more will be discussed today and tomorrow—stay tuned!

PRESENTED BY DUTCHIE

Dutchie's AI-powered platform provides tailored recommendations, from online browsing to in-store purchases.

Omnichannel personalization
Customer preferences and purchase history flow between online and in-store platforms, enabling highly personalized product recommendation

Customer behavior insights
Deeply understand your customers' preferences to optimize product offerings and discount strategies.

Superpower your budtenders
At-a-glance customer insights give budtenders the power to personalize every interaction.

AFC Gamma’s $100M Milestone, Rubicon’s Slashed Emissions

AFC Gamma recently crossed the $100M mark in new originations, funding a $41M credit facility for Story of Maryland, LLC, a vertically integrated cannabis operator. This highlights the growing investment opportunities in cannabis lending, as AFC continues to support scaling operations in the sector.

Meanwhile, Rubicon Organics is setting a new standard in sustainability, cutting its carbon footprint by 48% in 2023. Their latest ESG report also reveals a strong focus on diversity, with 83% of their workforce coming from underrepresented groups and women earning 33% more than men.

Hemp Wars: It’s New Jersey & Florida’s Turn Now

Hemp companies in New Jersey are suing the state over strict new regulations that limit the sale of hemp-derived products like Delta-8 THC. They argue that these rules violate the 2018 Farm Bill and could force many businesses to close by the October 12 deadline. 

Moreover, in Florida, experts are linking the state's legalization efforts to monopolistic goals. Industry leaders claim that big cannabis companies are pushing for market domination at the expense of smaller hemp operators. Conversely, Gov. Ron DeSantis is under heavy fire for using taxpayer money to fund anti-cannabis ads ahead of the November vote on Amendment 3. Weed out the competition, DeSantis and big cannabis said.

As hemp markets grow, the fight for fair regulation is heating up, with big players eyeing control and smaller ones fighting to survive.

It’s been two years since President Biden announced pardons for federal cannabis offenses, but here we are, still waiting. Despite the big headlines, around 3,000 people remain behind bars for weed-related charges. The Last Prisoner Project is urging Biden to act before his term ends, launching the #Countdown4Clemency campaign.

With 72% of voters backing clemency, it's a crowd-pleaser. Even Trump and Harris are chiming in on cannabis legalization. With time running out, will Biden leave office with unfinished business, or will he finally make good on his promise?

Stories In The Spotlight:

Our Writer Today

Patricio is a development economist with extensive experience in IT, finance, and banking. He writes about the economic and social opportunities obscured by over fifty years of drug prohibition. Beyond his professional expertise, Patricio is a committed advocate for social change, passionately working to promote harm reduction and reform drug policies.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Real Estate Weekly: Ready to elevate your real estate game? This weekly newsletter provides actionable insights whether you are investing in REITs, owning property, or delving into the fast-growing world of fractional real estate. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.